https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
89). The plasma circulating tumor DNA (ctDNA) detection rate in PTCs was only 38.9%, however, it was significantly associated with the metastatic status (p= 0.04), tumor size (p= 0.001) and invasiveness (p= 0.01). In conclusion, gene fusions and chromosome 22q loss were independently associated with DM in PTCs and could serve as molecular biomarkers for predicting DM. The ctDNA detection rate was low in non-DM PTCs but significantly higher in PTCs with DM. This article is protected by copyright. All rights reserved.PRO
Like
Comment
Share
